BioOrbit
Crystallizing pharmaceutical proteins in microgravity for better cancer drugs
BioOrbit operates in the in-space manufacturing sector of the space industry, is headquartered in United Kingdom, was founded in 2023, is at Seed stage.
BioOrbit at a glance
| Sector | In-Space Manufacturing |
|---|---|
| Headquarters | United Kingdom |
| Founded | 2023 |
| Stage | Seed |
| Website | bioorbit.com |
Record last updated August 2026 · how we verify · spotted something outdated? Tell us.
Funding history
| 2026-04 | Seed: GBP 9.8M, reported as the largest seed round yet for in-space manufacturingCo-led by LocalGlobe and Breega, with Auxxo, Seedcamp, Type One Ventures and 7percent Venturessource ↗ |
|---|
Backed by
Investors in BioOrbit who also back other space companies we track.
Follow startups like BioOrbit
Founder interviews and the most promising space startups, straight to your inbox. Free, no spam, unsubscribe anytime.